by Team Small News | Sep 25, 2025 | Natco, Pharma
Rajiv Nannapaneni, CEO of Natco Pharma, believes that the Indian pharma sector is not threatened by the recent US trade tariffs. He attributes this to the fact that the US consumes 92% of Indian generic drugs, making it reliant on Indian pharmaceuticals. Nannapaneni... by Team Small News | Sep 4, 2025 | Natco, Pharma
A patent battle is unfolding in India between Danish pharmaceutical company Novo Nordisk and Indian pharmaceutical companies, particularly Hyderabad-based Natco Pharma. The dispute centers around Novo Nordisk’s blockbuster weight-loss drug, semaglutide, which is... by Team Small News | Aug 23, 2025 | Natco, Pharma
Natco Pharma, an Indian pharmaceutical company, has filed a lawsuit against Novo Nordisk, a Danish multinational pharmaceutical company, in a Delhi court over intellectual property rights related to semaglutide. Semaglutide is a medication used to treat type 2... by Team Small News | Aug 2, 2025 | Natco, Pharma
Natco Pharma, a leading pharmaceutical company, has announced the appointment of TC Mallikarjun as Vice President – Quality Control (QC) at its Kothur Pharma Division. This appointment is a significant development for the company, as it continues to strengthen... by Team Small News | Jun 27, 2025 | Natco, Pharma
NATCO Pharma, a leading pharmaceutical company based in Hyderabad, India, has received a positive outcome from a recent US Food and Drug Administration (US FDA) audit. The company’s plant, located in Hyderabad, was inspected by the US FDA, and the audit resulted... by Team Small News | May 30, 2025 | Natco, Pharma
Natco Pharma Ltd, an Indian multinational pharmaceutical company, reported a 5% increase in consolidated net profit for the quarter ended March 31, 2025, with a net profit of ₹406 crore compared to ₹386.3 crore in the same period last year. The company’s...